Qizhe cardiomyogen in vitro reagent group - Taiwan Registration b211fd5c8be441579b909748183795a4
Access comprehensive regulatory information for Qizhe cardiomyogen in vitro reagent group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b211fd5c8be441579b909748183795a4 and manufactured by Longteng Biotechnology Co., Ltd. The authorized representative in Taiwan is Qizhe Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
Qualitative detection of Troponin I antibodies in human serum.
A Clinical chemistry and clinical toxicology
A.1215 Creatine phosphokinase/creatine kinase or isoenzyme testing system
Domestic;; Contract manufacturing
Dates and Status
Jan 07, 2014
Dec 07, 2016
Apr 25, 2018
Cancellation Information
Logged out
่ช่ก้ตๅ ฅ